British researchers found that a drug that combines glucagon and glucagon-like peptide 1 hormones helped participants consume 200 fewer calories from a heavy meal. The drug, currently available only as an infusion, may be taken as a once-weekly injection and may be ready for general use by 2020, researchers said. The findings were to be presented at the Society for Endocrinology meeting.
Diet drug shows efficacy in lowering calorie intake
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||